Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure

Nature Medicine
W A PaxtonR A Koup

Abstract

Some individuals remain uninfected with human immunodeficiency virus type-1 (HIV-1) despite multiple high-risk sexual exposures. We studied a cohort of 25 subjects with histories of multiple high-risk sexual exposures to HIV-1 and found that their CD8+ lymphocytes had greater anti-HIV-1 activity than did CD8+ lymphocytes from nonexposed controls. Further studies indicated that their purified CD4+ lymphocytes were less susceptible to infection with multiple primary isolates of HIV-1 than were CD4+ lymphocytes from the nonexposed controls. This relative resistance to HIV-1 infection did not extend to T-cell line-adapted strains, was restricted by the envelope glycoprotein, was not explained by the cell surface density of CD4 molecules, but was associated with the activity of the C-C chemokines RANTES, MIP-1alpha, and MIP-1beta. This relative resistance of CD4+ lymphocytes may contribute to protection from HIV-1 in multiply exposed persons.

References

Mar 1, 1992·The Journal of Infectious Diseases·M T RoosM Tersmette
Jun 1, 1992·AIDS Research and Human Retroviruses·C Mackewicz, J A Levy
Apr 1, 1992·Paediatric and Perinatal Epidemiology·J JustM C King
Aug 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·S BhatD H Silberberg
Jan 1, 1989·Journal of Clinical Epidemiology·V DeGruttolaC R Horsburgh
Jan 1, 1995·Nature Medicine·S Rowland-JonesT Corrah
Sep 1, 1994·Clinical and Experimental Immunology·M Z GhabanbasaniJ J Cassiman
Feb 1, 1993·AIDS Research and Human Retroviruses·M PatelM A Norcross

❮ Previous
Next ❯

Citations

Jan 1, 1997·Journal of Medical Virology·M Magierowska-JungJ M Huraux
May 8, 2001·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·S MahalingamP S Foster
Jan 1, 1997·Springer Seminars in Immunopathology·L Meyaard, F Miedema
Jan 1, 1997·Springer Seminars in Immunopathology·W A Paxton, R A Koup
Jul 1, 1997·Journal of Biomedical Science·R.B. MossF.C. Jensen
Jan 13, 2001·Springer Seminars in Immunopathology·D H McDermott, P M Murphy
Aug 5, 1998·International Journal of Clinical & Laboratory Research·J M WangJ J Oppenheim
Dec 23, 2004·Journal of Molecular Histology·Omar Bagasra, Kiley R Prilliman
Nov 28, 2007·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Marcus Kaul, Stuart A Lipton
Apr 25, 2012·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Italo MocchettiValeriya Avdoshina
Mar 9, 2006·Current HIV/AIDS Reports·Caroline T Tiemessen, Louise Kuhn
Jan 24, 2004·Mathematical Biosciences·Sara Del ValleShu-Fang Hsu Schmitz
May 26, 2004·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Sergey N Rumyantsev
Dec 5, 1998·Journal of Immunological Methods·J M WangS Su
May 17, 2000·Pharmaceutica acta Helvetiae·D J Triggle
Jul 27, 1996·Lancet·M B Feinberg
May 16, 2002·Molecular Immunology·Ali A Al Jabri
Apr 12, 2002·Veterinary Immunology and Immunopathology·J Norman FlynnOswald Jarrett
Oct 12, 2001·Immunology Letters·M CarringtonS J O'Brien
Jul 10, 1998·Immunology Letters·G A Passos, V P Picanço
Apr 15, 1999·Immunology Letters·M ClericiS Mazzoli
Jul 29, 1999·Immunology Letters·A KalinkovichZ Bentwich
Jan 1, 1997·Immunology Today·J L HeeneyS Zolla-Pazner
Oct 14, 1998·Trends in Genetics : TIG·S L Rowland-Jones
Jun 6, 2000·Advanced Drug Delivery Reviews·P J KlasseM Marsh
Jan 1, 1997·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Y Y ChoJ F Zagury
Jan 1, 1996·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·H HendelJ F Zagury
Mar 3, 1998·Cellular Signalling·A ScorzielloG Schettini
Aug 1, 1997·Current Opinion in Immunology·J P MooreT Dragic
Jan 1, 1997·Trends in Cell Biology·M MarshJ A Hoxie

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.